Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A Randomized Phase II, Open Label, Study of...
Conference

A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma

Authors

Sebag M; Kouroukis T; Bahlis N; Venner C; McCurdy A; Shustik J

Publication Date

November 13, 2019

Name of conference

American Society of Hematology

Associated Experts

Tom Kouroukis

Professor, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3201 Cardiovascular medicine and haematology3202 Clinical Sciences3211 Oncology and Carcinogenesis3101 Biochemistry and cell biology3213 Paediatrics